Live Breaking News & Updates on Newton Guerin

Stay updated with breaking news from Newton guerin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Iopofosine I 131 Generates Early Efficacy Signals in Waldenström Macroglobulinemia

Iopofosine I 131 monotherapy elicited durable responses and was associated with a tolerable safety profile in patients with heavily pretreated, multi-class refractory Waldenström macroglobulinemia. ....

James Caruso , Cellectar Biosciences , Iopofosinei 131 Monotherapy , Patients With Heavily Pretreated , Ulti Class Refractory Waldenström Macroglobulinemia , Clover Wam Trial , Sikander Ailawadhi , Mayo Clinic , Newton Guerin ,